Glide Pharmaceutical Technologies

About:

Glide Pharma is a specialty pharmaceutical company that develops products for the convenient delivery of biological medicines.

Website: http://glide-technologies.com/

Top Investors: Invesco, Oxford Capital, Oxford Technology Management, Hygea VCT

Description:

Glide Pharmaceutical Technologies is a clinical stage development company that focuses on solid dose formulations of therapeutics and vaccines. The company develops SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. Glide Pharmaceutical Technologies was formerly known as Caretek Medical.

Total Funding Amount:

$37.8M

Headquarters Location:

Abingdon, Oxfordshire, United Kingdom

Founded Date:

2001-01-01

Contact Email:

enquiries(AT)glidepharma.com

Founders:

Charles Potter

Number of Employees:

11-50

Last Funding Date:

2017-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai